首页> 外国专利> COMPOSITION FOR PROTECTION OR TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIOUS DISEASES COMPRISING FRACTION FROM VITIS AMURENSIS

COMPOSITION FOR PROTECTION OR TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIOUS DISEASES COMPRISING FRACTION FROM VITIS AMURENSIS

机译:用于预防或治疗耐甲氧西林的金黄色葡萄球菌感染性疾病的组合物

摘要

It is used to prevent and treat infectious disease Methicillin-resistantStaphylococcusaureus (MRSA) the present invention relates to one kind, including ethyl acetate fraction Vitisamurensis root extracts are as active constituent. In addition, the present invention relates to one kind for preventing and improving non-MRSA infectious diseases, including ethyl acetate fraction Vitisamurensis root extracts as active constituent, and the animal other than the mankind for treating MRSA infectious diseases, it includes that management pharmaceutical composition is MRSA infectious diseases suspected case. Composition of the invention can be effectively used for preventing, treating or improving MRSA infectious diseases. Ethyl acetate fraction Vitisamurensis root extracts are active constituents of the invention, this to freely compose drug when can provide safe medicine side effect and comparing. ;The 2015 of copyright KIPO submissions
机译:它是用于预防和治疗传染病的耐甲氧西林金黄色葡萄球菌(MRSA),本发明涉及一种,其中乙酸乙酯级分Vitisamurensis的根提取物均作为活性成分。另外,本发明涉及一种预防和改善非MRSA感染性疾病的方法,以乙酸乙酯级分Vitisamurensis根提取物为有效成分,以及除人类以外的用于治疗MRSA感染性疾病的动物,包括管理药物组合物。是MRSA传染病的疑似病例。本发明的组合物可以有效地用于预防,治疗或改善MRSA感染性疾病。乙酸乙酯级分Vitisamurensis根提取物是本发明的活性成分,这可以在提供安全的药物副作用和比较时自由地组成药物。 ; 2015年版权KIPO提交文件

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号